Phagocytosis and Immune Regulation
Phagocytosis and Immune Regulation is a research topic within Immunology. Science Explorer counts 17k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the mechanisms and regulation of apoptotic cell clearance, including the role of CD47, phagocytosis, TAM receptors, efferocytosis, and the implications for cancer immunotherapy. It explores the involvement of various molecules and pathways in the recognition and removal of apoptotic cells by phagocytes, shedding light on potential therapeutic targets for immune-related diseases.
- CD47
- apoptotic cells
- phagocytosis
- immune regulation
- clearance mechanisms
- TAM receptors
- efferocytosis
- cancer immunotherapy
- phosphatidylserine
- macrophages
- Research works
- 17k fractional, since 1950
- In the world top 10%
- 1.7k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +32% the tick is no change
- Largest producer
China
42% of the 10 largest, 2022-now
Which countries lead Phagocytosis and Immune Regulation research?
By volume, China and the United States publish the most (1.6k and 1.2k works in 2022-now).
By volume, 2022-now
- 1
China 1.6k works
- 2
United States 1.2k works
- 3
Germany 177 works
- 4
Japan 158 works
- 5
United Kingdom 142 works
- 6
India 125 works
- 7
France 117 works
- 8
South Korea 105 works
- 9
Italy 94 works
- 10
Canada 88 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Phagocytosis and Immune Regulation research?
By volume in 2022-now, Sun Yat-sen University publishes the most Phagocytosis and Immune Regulation research, followed by Harvard University and Shanghai Jiao Tong University.
By volume, 2022-now
- 1
Sun Yat-sen University
China 54 works
- 2
Harvard University
United States 54 works
- 3
Shanghai Jiao Tong University
China 48 works
- 4
Zhejiang University
China 40 works
- 5
Sichuan University
China 40 works
- 6
Chinese Academy of Sciences
China 35 works
- 7
Chinese Academy of Medical Sciences & Peking Union Medical College
China 33 works
- 8
University of North Carolina at Chapel Hill
United States 33 works
- 9
National Institutes of Health
United States 32 works
- 10
The University of Texas MD Anderson Cancer Center
United States 32 works
Who are the leading researchers in Phagocytosis and Immune Regulation?
The most-cited researchers publishing on Phagocytosis and Immune Regulation include Mark J. Daly, Guido Kroemer and Shizuo Akira.
- 1
Mark J. Daly
United States 403k citations
- 2
Guido Kroemer
France 386k citations
- 3
Shizuo Akira
Japan 342k citations
- 4
Jun Wang
China 340k citations
- 5
Giuseppe Remuzzi
Italy 328k citations
- 6
Gregory Y.H. Lip
United Kingdom 311k citations
- 7
Robert A. Weinberg
United States 301k citations
- 8
Michael Karin
United States 276k citations
- 9
Hagop M. Kantarjian
United States 273k citations
- 10
Gordon Brent Mills
United States 265k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Phagocytosis and Immune Regulation research done?
The largest centres of Phagocytosis and Immune Regulation research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda and Houston.
Largest cities, 2022-now
Where it is the local speciality
- BethesdaUS · 31.2 works5.7×
- HoustonUS · 53.7 works4.8×
Location quotient: how much more of its research is in Phagocytosis and Immune Regulation than the world average.
Where is the best place to study Phagocytosis and Immune Regulation?
Among universities, judged by research, Harvard University, Sun Yat-sen University and Sichuan University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Phagocytosis and Immune Regulation, country by countryIs Phagocytosis and Immune Regulation research growing?
Output in 2022-2025 was 32% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Phagocytosis and Immune Regulation.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Phagocytosis and Immune Regulation as a percentage of every work published that year, 0.018% in 2024.
Fractional works of Phagocytosis and Immune Regulation over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Phagocytosis and Immune Regulation. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.